BioNTech's Annual General Meeting was held on May 16, 2025, without the physical presence of shareholders or their proxies (with the exception of the company's proxies), with 95.25 per cent of the registered share capital represented. The shareholders approved all resolutions. The voting results can be found on this page.
Letter from Helmut Jeggle, Chairman of the Supervisory Board of BioNTech
Information and Documents Relating to the Annual General Meeting
Invitation to the 2025 Annual General Meeting
Documents on Agenda Item 1
Documents on Agenda Item 2
Documents on Agenda Item 6
Documents on Agenda Item 7
Further Documents and Forms
Speech and Presentation
Voting Results
